Multiple Sclerosis (MS) is an autoimmune inflammatory disease that affects the Central Nervous System (CNS) by interfering with nerve signal transmission. Relapse Remitting Multiple Sclerosis (RRMS) is defined by a repeated cycle of flare-ups (relapse stage) and remission (period of normal functioning). Approximately 85% of MS cases are diagnosed during the Relapse Remitting Multiple Sclerosis stage as opposed to the progressive stage. Women are affected by RRMS between 2 and 3 times as often as men. RRMS is defined by inflammation that targets myelin specifically; this type of inflammation does not occur in progressive forms of MS. Advancement to progressive forms of Multiple Sclerosis from Relapse Remitting Multiple Sclerosis typically occur 10 years after diagnosis.
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Multiple Sclerosis, Relapsing-remitting below!
For more information on how to use Laverne, please read the How to Guide.
We have 3315 products for the study of Multiple Sclerosis, Relapsing-remitting that can be applied to Western Blot, Chromatin Immunoprecipitation, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.